Clinical Trials Browser

Phase 2 × Lung Neoplasms × vandetanib × Clear all

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00459121 2019-03-26

Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery

Phase 2 Terminated

2 enrolled 4 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00687297 2018-05-30

Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer

Phase 2 Completed

162 enrolled 9 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00753714 2016-10-17

ZELIG

Phase 2 Completed

124 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion

NCT00066313 2016-08-24

ZD6474 in Treating Patients With Small Cell Lung Cancer

Phase 2 Completed

Thoracic

Lung Neoplasms

NCT00290537 2016-05-19

Phase II Study of ZD6474 in Advanced NSCLC

Phase 2 Terminated

4 enrolled 3 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00402896 2016-03-09

Malignant Pleural Effusion With ZD6474

Phase 2 Terminated

28 enrolled 5 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion

NCT00410189 2015-03-23

BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC

Phase 2 Completed

54 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Vandetanib in Advanced NSCLC With RET Rearrangement

Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery

Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer

ZELIG

ZD6474 in Treating Patients With Small Cell Lung Cancer

Phase II Study of ZD6474 in Advanced NSCLC

Malignant Pleural Effusion With ZD6474

BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC